Avalo Therapeutics, Inc. (AVTX) Earnings
NASDAQ·Healthcare·Biotechnology
$18.04
+0.33%
Mkt Cap $218.99M
EPS — Estimate vs Actual
Mkt Cap
$218.99M
P/E
—
Fwd P/E
—
P/S
3711.75
Rev TTM
—
EPS TTM
-$5.83
NASDAQ·Healthcare·Biotechnology
$18.04
+0.33%
Mkt Cap $218.99M
Mkt Cap
$218.99M
P/E
—
Fwd P/E
—
P/S
3711.75
Rev TTM
—
EPS TTM
-$5.83